The KNOW-CKD study: What we have learned about chronic kidney diseases

KNOW-CKD Study Investigators

doi:10.23876/j.krcp.20.042

The KNOW-CKD study: What we have learned about chronic kidney diseases

KNOW-CKD Study Investigators

Department of Internal Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

As the nation’s largest chronic kidney disease (CKD) cohort, the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) was established to investigate the clinical course, risk factors for progression, and adverse outcomes of CKD. From 2011 to 2016, the KNOW-CKD recruited 2,238 adult patients with CKD from stage G1 to G5 who were not receiving renal replacement therapy from nine tertiary care hospitals throughout Korea. As of 2019, the KNOW-CKD has published more than 50 articles in the areas of socio-economics, nutrition, quality of life, health-related habits, CKD progression, cardiovascular comorbidity and outcome, anemia, mineral bone disease, biomarker discovery, and international and inter-ethnic comparisons. The KNOW-CKD will eventually offer a prediction model for long-term consequences of CKD, such as the occurrences of end-stage renal disease, cardiovascular disease, and death, thereby enabling the identification and treatment of at-risk populations that require extra medical attention.

Original language	English
Pages (from-to)	121-135
Number of pages	15
Journal	Kidney Research and Clinical Practice
Volume	39
Issue number	2
DOIs	https://doi.org/10.23876/j.krcp.20.042
Publication status	Published - 2020 Jun

Bibliographical note

Funding Information:
This study was supported by the Research Program funded by the Korea Center for Disease Control and Prevention (2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200, and 2019E320100).

All Science Journal Classification (ASJC) codes

Nephrology
Urology

Access to Document

10.23876/j.krcp.20.042

Fingerprint Dive into the research topics of 'The KNOW-CKD study: What we have learned about chronic kidney diseases'. Together they form a unique fingerprint.

Cite this

@article{ec9939a95c7f4c019d83edc6f370d599,

title = "The KNOW-CKD study: What we have learned about chronic kidney diseases",

abstract = "As the nation{\textquoteright}s largest chronic kidney disease (CKD) cohort, the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) was established to investigate the clinical course, risk factors for progression, and adverse outcomes of CKD. From 2011 to 2016, the KNOW-CKD recruited 2,238 adult patients with CKD from stage G1 to G5 who were not receiving renal replacement therapy from nine tertiary care hospitals throughout Korea. As of 2019, the KNOW-CKD has published more than 50 articles in the areas of socio-economics, nutrition, quality of life, health-related habits, CKD progression, cardiovascular comorbidity and outcome, anemia, mineral bone disease, biomarker discovery, and international and inter-ethnic comparisons. The KNOW-CKD will eventually offer a prediction model for long-term consequences of CKD, such as the occurrences of end-stage renal disease, cardiovascular disease, and death, thereby enabling the identification and treatment of at-risk populations that require extra medical attention.",

author = "{KNOW-CKD Study Investigators} and Oh, {Kook Hwan} and Minjung Kang and Eunjeong Kang and Hyunjin Ryu and Han, {Seung Hyeok} and Yoo, {Tae Hyun} and Kim, {Soo Wan} and Chae, {Dong Wan} and Lee, {Kyu Beck} and Park, {Sue K.} and Kim, {Yeong Hoon} and Curie Ahn",

note = "Funding Information: This study was supported by the Research Program funded by the Korea Center for Disease Control and Prevention (2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200, and 2019E320100).",

year = "2020",

month = jun,

doi = "10.23876/j.krcp.20.042",

language = "English",

volume = "39",

pages = "121--135",

journal = "Kidney Research and Clinical Practice",

issn = "2211-9132",

publisher = "Elsevier Korea",

number = "2",

}

TY - JOUR

T1 - The KNOW-CKD study

T2 - What we have learned about chronic kidney diseases

AU - KNOW-CKD Study Investigators

AU - Oh, Kook Hwan

AU - Kang, Minjung

AU - Kang, Eunjeong

AU - Ryu, Hyunjin

AU - Han, Seung Hyeok

AU - Yoo, Tae Hyun

AU - Kim, Soo Wan

AU - Chae, Dong Wan

AU - Lee, Kyu Beck

AU - Park, Sue K.

AU - Kim, Yeong Hoon

AU - Ahn, Curie

N1 - Funding Information: This study was supported by the Research Program funded by the Korea Center for Disease Control and Prevention (2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200, and 2019E320100).

PY - 2020/6

Y1 - 2020/6

N2 - As the nation’s largest chronic kidney disease (CKD) cohort, the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) was established to investigate the clinical course, risk factors for progression, and adverse outcomes of CKD. From 2011 to 2016, the KNOW-CKD recruited 2,238 adult patients with CKD from stage G1 to G5 who were not receiving renal replacement therapy from nine tertiary care hospitals throughout Korea. As of 2019, the KNOW-CKD has published more than 50 articles in the areas of socio-economics, nutrition, quality of life, health-related habits, CKD progression, cardiovascular comorbidity and outcome, anemia, mineral bone disease, biomarker discovery, and international and inter-ethnic comparisons. The KNOW-CKD will eventually offer a prediction model for long-term consequences of CKD, such as the occurrences of end-stage renal disease, cardiovascular disease, and death, thereby enabling the identification and treatment of at-risk populations that require extra medical attention.

AB - As the nation’s largest chronic kidney disease (CKD) cohort, the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) was established to investigate the clinical course, risk factors for progression, and adverse outcomes of CKD. From 2011 to 2016, the KNOW-CKD recruited 2,238 adult patients with CKD from stage G1 to G5 who were not receiving renal replacement therapy from nine tertiary care hospitals throughout Korea. As of 2019, the KNOW-CKD has published more than 50 articles in the areas of socio-economics, nutrition, quality of life, health-related habits, CKD progression, cardiovascular comorbidity and outcome, anemia, mineral bone disease, biomarker discovery, and international and inter-ethnic comparisons. The KNOW-CKD will eventually offer a prediction model for long-term consequences of CKD, such as the occurrences of end-stage renal disease, cardiovascular disease, and death, thereby enabling the identification and treatment of at-risk populations that require extra medical attention.

UR - http://www.scopus.com/inward/record.url?scp=85086944446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086944446&partnerID=8YFLogxK

U2 - 10.23876/j.krcp.20.042

DO - 10.23876/j.krcp.20.042

M3 - Review article

AN - SCOPUS:85086944446

VL - 39

SP - 121

EP - 135

JO - Kidney Research and Clinical Practice

JF - Kidney Research and Clinical Practice

SN - 2211-9132

IS - 2

ER -